Kwon Sung Woo, Kang Seong-Woong, Kim Jong-Youn, Choi Eui-Young, Yoon Young Won, Park Yoo Mi, Ma Dae Won, Chung Hyemoon, Kwon Hyuck Moon, Rim Se-Joong
Division of Cardiology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Cardiology. 2012;121(3):186-93. doi: 10.1159/000336810. Epub 2012 Apr 12.
The purpose of this study was to investigate the clinical outcome as well as the sequential changes of cardiac function in late-stage Duchenne muscular dystrophy (DMD) patients by 2-dimensional echocardiography.
A total of 31 individuals (initial age: 21.6 ± 5.0 years, range: 15-35 years) with late-stage DMD (Swinyard-Deaver's stage 7 or 8) were enrolled. All of these patients had respiratory insufficiency and were on ventilator support. Sequential echocardiographic data were collected over at least 3 years. Repeated measures analysis of variance was used to compare changes in left ventricular ejection fraction (LVEF) over time.
The sequential change in the mean LVEF showed no significant differences with initial, 1-, 2-, and 3-year follow-up LVEFs which were 42.2, 42.9, 43.8 and 42.6%, respectively (p = 0.320). In terms of the clinical outcome, all but 1 patient survived during the follow-up period of 46.5 ± 9.1 months.
The cardiac function in late-stage DMD patients showed a stabilization of LVEF on adequate ventilatory support and optimal cardiac medication therapy until their mid-30s. In addition, considering the favorable clinical outcome in our study, the process of cardiac involvement in late-stage DMD may demonstrate that in some patients it is nonprogressive.
本研究旨在通过二维超声心动图研究晚期杜氏肌营养不良症(DMD)患者的临床结局以及心功能的连续变化。
共纳入31例晚期DMD患者(初始年龄:21.6±5.0岁,范围:15 - 35岁)(Swinyard - Deaver分期为7期或8期)。所有这些患者均有呼吸功能不全且接受呼吸机支持。至少3年收集连续的超声心动图数据。采用重复测量方差分析比较左心室射血分数(LVEF)随时间的变化。
平均LVEF的连续变化与初始、1年、2年和3年随访时的LVEF无显著差异,分别为42.2%、42.9%、43.8%和42.6%(p = 0.320)。在临床结局方面,除1例患者外,所有患者在46.5±9.1个月的随访期内均存活。
晚期DMD患者的心功能在适当的通气支持和最佳心脏药物治疗下,直到35岁左右LVEF保持稳定。此外,考虑到我们研究中良好的临床结局,晚期DMD心脏受累的过程可能表明在某些患者中它是不进展的。